Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer TreatmentsJ Matt McCrary, David Goldstein, Terry Trinh, et al.
Haematologica|September 28, 2023
Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II studyChristopher R Flowers, Matthew J Matasar, Alex F Herrera, et al.
Cancer Medicine|April 26, 2016
Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT)Gemma Dyer, Stephen R Larsen, Nicole Gilroy, et al.
Cancer Medicine|October 30, 2016
Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in AustraliaJulian Lindsay, Masrura Kabir, Nicole Gilroy, et al.
Haematologica|December 15, 2018
Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemiaMelita Kenealy, Mark Hertzberg, Warwick Benson, et al.
Clinical Nursing Research|June 17, 2023
Decisional Regret in Long-Term Australian Allogeneic Hematopoietic Stem Cell Transplantation Survivors: A Cross-Sectional SurveyGemma McErlean, Caley Tapp, Lisa Brice, et al.
British Journal of Haematology|February 6, 2016
A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, AustraliaGemma Dyer, Nicole Gilroy, Jennifer Bradford, et al.
Leukemia & Lymphoma|February 15, 2014
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemiaStephen P Mulligan, Karin Karlsson, Mats Strömberg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 3, 2016
Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW AustraliaJennifer Smith, Christine Poon, Nicole Gilroy, et al.
American Journal of Hematology|February 1, 2014
A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trialMark Hertzberg, Jane Palfrey Matthews, Janey Malka Stone, et al.
Pageof 9